Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors?
The cannabinoid type-2 G protein-coupled (CB2) receptor is an emerging therapeutic target for pain management and immune system modulation. In a mouse model of Alzheimer’s disease (AD) the orally administered natural product 4′-O-methylhonokiol (MH) has been shown to prevent amyloidogenesis and prog...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
BioMed Central
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419612/ |